Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice
- PMID: 17618414
- DOI: 10.1007/s00125-007-0738-5
Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice
Abstract
Aims/hypothesis: Complex changes in gene expression are associated with insulin resistance and non-alcoholic fatty liver disease (NAFLD) promoted by feeding a high-fat diet (HFD). We used functional genomic technologies to document molecular mechanisms associated with diet-induced NAFLD.
Materials and methods: Male 129S6 mice were fed a diet containing 40% fat (high-fat diet, HFD) for 15 weeks. Glucose tolerance, in vivo insulin secretion, plasma lipid profile and adiposity were determined. Plasma metabonomics and liver transcriptomics were used to identify changes in gene expression associated with HFD-induced NAFLD.
Results: In HFD-fed mice, NAFLD and impaired glucose and lipid homeostasis were associated with increased hepatic transcription of genes involved in fatty acid uptake, intracellular transport, modification and elongation, whilst genes involved in beta-oxidation and lipoprotein secretion were, paradoxically, also upregulated. NAFLD developed despite strong and sustained downregulation of transcription of the gene encoding stearoyl-coenzyme A desaturase 1 (Scd1) and uncoordinated regulation of transcription of Scd1 and the gene encoding sterol regulatory element binding factor 1c (Srebf1c) transcription. Inflammatory mechanisms appeared to be stimulated by HFD.
Conclusions/interpretation: Our results provide an accurate representation of subtle changes in metabolic and gene expression regulation underlying disease-promoting and compensatory mechanisms, collectively contributing to diet-induced insulin resistance and NAFLD. They suggest that proposed models of NAFLD pathogenesis can be enriched with novel diet-reactive genes and disease mechanisms.
Similar articles
-
Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.Metabolism. 2013 Nov;62(11):1651-61. doi: 10.1016/j.metabol.2013.06.012. Epub 2013 Aug 5. Metabolism. 2013. PMID: 23928105
-
Peri-conceptional obesogenic exposure induces sex-specific programming of disease susceptibilities in adult mouse offspring.Biochim Biophys Acta. 2014 Feb;1842(2):304-17. doi: 10.1016/j.bbadis.2013.11.021. Epub 2013 Nov 23. Biochim Biophys Acta. 2014. PMID: 24275555
-
Fatty liver is associated with transcriptional downregulation of stearoyl-CoA desaturase and impaired protein dimerization.PLoS One. 2013 Sep 30;8(9):e76912. doi: 10.1371/journal.pone.0076912. eCollection 2013. PLoS One. 2013. PMID: 24098813 Free PMC article.
-
[Retinoids as promising treatment for non-alcoholic fatty liver disease].Yakugaku Zasshi. 2012;132(8):903-9. doi: 10.1248/yakushi.132.903. Yakugaku Zasshi. 2012. PMID: 22864348 Review. Japanese.
-
Role of transcription factor modifications in the pathogenesis of insulin resistance.Exp Diabetes Res. 2012;2012:716425. doi: 10.1155/2012/716425. Epub 2011 Oct 26. Exp Diabetes Res. 2012. PMID: 22110478 Free PMC article. Review.
Cited by
-
Virgin Coconut Oil Associated with High-Fat Diet Induces Metabolic Dysfunctions, Adipose Inflammation, and Hepatic Lipid Accumulation.J Med Food. 2020 Jul;23(7):689-698. doi: 10.1089/jmf.2019.0172. Epub 2019 Dec 3. J Med Food. 2020. PMID: 31800339 Free PMC article.
-
Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans.Diabetologia. 2008 Apr;51(4):648-56. doi: 10.1007/s00125-008-0938-7. Epub 2008 Feb 20. Diabetologia. 2008. PMID: 18286258
-
Diagnosis and Staging of Metabolic Dysfunction-Associated Steatotic Liver Disease Using Biomarker-Directed Aptamer Panels.Biomolecules. 2025 Feb 10;15(2):255. doi: 10.3390/biom15020255. Biomolecules. 2025. PMID: 40001558 Free PMC article.
-
Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide.Eur J Pharmacol. 2009 Oct 12;620(1-3):138-44. doi: 10.1016/j.ejphar.2009.08.022. Epub 2009 Aug 19. Eur J Pharmacol. 2009. PMID: 19698707 Free PMC article.
-
L-tryptophan-mediated enhancement of susceptibility to nonalcoholic fatty liver disease is dependent on the mammalian target of rapamycin.J Biol Chem. 2011 Oct 7;286(40):34800-8. doi: 10.1074/jbc.M111.235473. Epub 2011 Aug 12. J Biol Chem. 2011. PMID: 21841000 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical